PLAT and prostate carcinoma: obtained from mean serum CEA, TPA, CA15.3, CA125, HE4, and PSA lead time for “early” detection of relapse during postoperative monitoring of untreated, disease‐free breast, colorectal, ovarian, and prostate cancer patients.